The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Septrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension



Aspen Pharma Trading LimitedPA1691/010/003

Main Information

Trade NameSeptrin Paediatric 40 mg/200 mg per 5 ml Oral Suspension
Active SubstancesSulphamethoxazole
Trimethoprim
Dosage FormOral suspension
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/010/003

Group Information

ATC CodeJ01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
J01EE01 sulfamethoxazole and trimethoprim

Status

License statusAuthorised
Licence Issued14/11/1975
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back